🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robert D. Allen

National Laboratory of the Rockies

ORCID: 0000-0001-9950-103X

Also affiliated with Department of the Environment

EngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19”.

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

Med(2024)10.1016/j.medj.2023.12.004
N/A
1.2DataRank · unranked
38 citations

Namir Shaabani, Xiaoying Zhang, Can Jin, Wanhong Xu, Christopher Argent +36 more

An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody

mBio(2023)10.1128/mbio.02477-23
N/A
0.444DataRank · unranked
8 citations

Luca Brambilla, Daniel C. Adelsberg, Shreyas Kowdle, Christian S. Stevens, Stefan Slamanig +11 more

Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.19.476998
N/A
0.330DataRank · unranked
8 citations

Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Soner Yildiz +43 more

The P3 O - Tert -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.18.473326
N/A
0DataRank · unranked
3 citations

Kai S. Yang, Zhi Geng, Yugendar R. Alugubelli, Namir Shaabani, Erol C. Vatansever +12 more

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.17.524469
N/A
0DataRank · unranked
4 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.20.537738
N/A
0DataRank · unranked
0 citations

Luca Brambilla, Daniel C. Adelsberg, Shreyas Kowdle, Christian S. Stevens, Chuan-Tien Hung +9 more

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00221
N/A
0DataRank · unranked
25 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114596
N/A
0DataRank · unranked
55 citations

Zhi Geng, Kai S. Yang, Namir Shaabani, Kaustav Khatua, R. Xinyu +13 more

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114570
N/A
0DataRank · unranked
43 citations

Kai S. Yang, Zhi Geng, Yugendar R. Alugubelli, Namir Shaabani, Erol C. Vatansever +13 more